Protalix BioTherapeutics (PLX) Gross Profit Growth (3y) (2013 - 2026)
Protalix BioTherapeutics (PLX) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.18% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Protalix BioTherapeutics | 192.04 Mn | 181.24 Mn | 29.62 Mn | 65.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.77% |
| Dec 31, 2025 | -10.21% |
| Sep 30, 2025 | 10.25% |
| Jun 30, 2025 | 28.01% |
| Mar 31, 2025 | -42.28% |
| Dec 31, 2024 | 38.45% |
| Sep 30, 2024 | 4.70% |
| Jun 30, 2024 | 33.36% |
| Mar 31, 2024 | -44.08% |
| Dec 31, 2023 | -54.00% |
| Sep 30, 2023 | -11.71% |
| Jun 30, 2023 | 46.82% |
| Mar 31, 2023 | -29.07% |
| Dec 31, 2022 | -17.38% |
| Sep 30, 2022 | -13.65% |
| Jun 30, 2022 | -21.24% |
| Mar 31, 2022 | 6.19% |
| Dec 31, 2021 | 131.13% |
| Sep 30, 2021 | 105.35% |
| Jun 30, 2021 | 126.18% |